Analyst Price Target is $287.00
▼ -5.96% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for Mesa Laboratories in the last 3 months. The average price target is $287.00, with a high forecast of $287.00 and a low forecast of $287.00. The average price target represents a -5.96% upside from the last price of $305.20.
Current Consensus is
The current consensus among 1 investment analysts is to hold stock in Mesa Laboratories. This rating has held steady since October 2020, when it changed from a Buy consensus rating.
Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. It operates through the following segments: Sterilization and Disinfection Control, Instruments, Continuous Monitoring, and Biopharmaceutical Development. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators. The Instrument segment designs, manufactures, and markets control instruments and disposable products used in the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, and environmental air sampling industries. The Biopharmaceutical Development segment develops and sells automated systems for protein analysis and peptide synthesis solutions. The Continuous Monitoring segment includes development of systems used to monitor various environmental parameters. The company was founded by Luke R. Schmieder on March 26, 1982 and is headquartered in Lakewood, CO.